文献速递中毒与环境急症儿科与产科急症

儿童利培酮用药错误:法国毒物中心数据分析

Risperidone medication errors in children: an analysis of French poison centres data.
PubMed 文献 · Clin Toxicol (Phila) · 2018-11-17
一句话结论儿童利培酮用药错误多仅致嗜睡和轻度锥体外系反应,暴露剂量≤0.15 mg/kg者可居家观察。

该研究分析了2001至2012年法国毒物中心管理的160例13岁以下儿童利培酮用药错误病例,纳入标准为摄入后至少2小时无症状、摄入剂量超过5岁以上儿童最大日剂量两倍或首次接触时有症状。中位年龄8岁(范围0.9-12),28.1%为5岁及以下。错误原因为治疗儿童剂量错误(84.2%)或给错儿童(15.8%)。中位摄入剂量0.1 mg/kg或最大推荐剂量的3.3倍。59例无症状,95例轻微症状,6例中度症状,嗜睡/镇静最常见(73.3%)。17例发生锥体外系障碍,均为轻微或中度症状,仅5例需对症治疗。结论认为儿童利培酮用药错误影响轻微,主要毒性为嗜睡和轻中度锥体外系反应,未观察到显著心脏或其他神经系统特征,无严重毒性病例。暴露剂量≤0.15 mg/kg的儿童可建议居家观察。

要点

  • 160例13岁以下儿童利培酮用药错误中,59例无症状,95例轻微症状,6例中度症状,无严重毒性病例。
  • 嗜睡/镇静最常见(73.3%),17例发生锥体外系障碍,均为轻微或中度,仅5例需对症治疗。
  • 中位摄入剂量为0.1 mg/kg或最大推荐剂量的3.3倍,未观察到显著心脏或其他神经系统特征。
  • 暴露剂量≤0.15 mg/kg的儿童可建议居家观察。

适用人群与场景

  • 13岁以下儿童,因利培酮用药错误(剂量错误或给错儿童)经法国毒物中心管理。
  • 纳入标准:摄入后至少2小时无症状且摄入剂量超过5岁以上儿童最大日剂量两倍,或首次接触时有症状。

诊断标准与关键阈值

  • 暴露剂量≤0.15 mg/kg可建议居家观察。

处置流程与药物剂量

  • 对暴露剂量≤0.15 mg/kg的儿童可建议居家观察。
  • 17例发生锥体外系障碍的儿童中,5例需对症治疗。

研究设计与关键结果

  • 研究类型为法国毒物中心数据回顾性分析,样本量160例,人群为13岁以下儿童利培酮用药错误。
  • 中位年龄8岁(范围0.9-12),28.1%为5岁及以下;错误原因为治疗儿童剂量错误(84.2%)或给错儿童(15.8%)。
  • 中位摄入剂量0.1 mg/kg或最大推荐剂量的3.3倍。
  • 59例无症状,95例轻微症状,6例中度症状;嗜睡/镇静最常见(73.3%)。
  • 17例发生锥体外系障碍,均为轻微或中度症状,仅5例需对症治疗;未观察到显著心脏或其他神经系统特征,无严重毒性病例。

证据类型、等级与局限

  • 证据类型:基于法国毒物中心数据的回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 儿童利培酮用药错误多仅引起嗜睡和轻中度锥体外系反应,无严重毒性,暴露剂量≤0.15 mg/kg者可建议居家观察。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To describe clinical consequences of risperidone medication errors in children of less than 13 years and to estimate a clinically relevant toxic dose.

METHODS: All cases of risperidone medication errors managed by French Poison Centres from 2001 to 2012 were analyzed. Inclusion criteria were a delay of at least 2 hours between ingestion and request to the FPC in asymptomatic children, an ingested dose above two-fold the maximal daily dose for children above 5 years or any symptomatic patient at the time of first contact.

RESULTS: One hundred and sixty cases met our criteria. Median age was 8 years (range 0.9-12) and 28.1% were aged 5 years or less. Causes of the error were an incorrect dose in treated children (84.2%) or a dose given to a wrong child (15.8%). The median ingested dose was 0.1 mg/kg or 3.3-fold the maximum recommended dose. Overall, 59 children had no symptoms, 95 experienced minor symptoms and six moderate symptoms. Somnolence/sedation was the most common (73.3%). Of the 17 children who developed extrapyramidal disorders, all had minor or moderate symptoms and only five required a symptomatic treatment.

CONCLUSIONS: Risperidone medication errors in children cause minimal effects. Somnolence and mild to moderate extrapyramidal reactions were the main features of toxicity, and significant cardiac or other neurological features were not observed. No case with severe toxicity was noted. At home surveillance can be proposed for children exposed to a dose ≤0.15 mg/kg.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Vial T, Patat AM, Paret N, et al. Risperidone medication errors in children: an analysis of French poison centres data. Clin Toxicol (Phila). 2018. PMID: 30449187. doi:10.1080/15563650.2018.1523424

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。